Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Aesthetic Plastic Surgery
Published in: Aesthetic Plastic Surgery 5/2022

20-01-2022 | Fat Grafting | Original Article

The Effect of Lipofilling and Platelet-Rich Plasma on Patients with Moderate–Severe Vulvar Lichen Sclerosus who were Non-Responders to Topical Clobetasol Propionate: A Randomized Pilot Study

Published in: Aesthetic Plastic Surgery | Issue 5/2022

Login to get access

Abstract

Background

The first-line treatment for vulvar lichen sclerosus (VLS) is 3 months of topical corticosteroid therapy. However, limited evidence is available concerning the use of fat grafting and platelet-rich plasma as a second-line treatment for patients who do not respond to first-line treatment.

Methods

This prospective single-center randomized pilot trial included 20 patients with a clinical and histological diagnosis of moderate to severe VLS. The patients in the treatment group (TG) received two infiltrations (at 3-month intervals) of nanofat mixed with platelet-rich plasma (PRP) into the vulvar area, while the control group (CG) received standard topical corticosteroid therapy. Fat was aspirated from the medial thigh or lower abdomen regions. Microfat was obtained after centrifugation and was emulsified to obtain a nanofat suspension. Treatment efficacy was determined by measuring changes in the vulvar skin elasticity, histopathology, and clinical signs, symptoms, and patient quality of life at after 1 year.

Results

A total of 19 patients were finally assessed (9 TG and 10 CG). At the end of the study (1 year), there had been no significant improvement in vulvar skin elasticity. However, patients in the TG showed a significant improvement in their symptoms (itching, pain, burning, and dyspareunia) and clinical signs (cervical erosions, fissures, stenosis, and leukoderma). Analysis of skin biopsies revealed a significant decrease in all inflammatory cell types in the TG. No adverse events related to the autologous treatment were recorded.

Conclusions

Compared with topical corticosteroids, two infiltrations delivered 3 months apart decreased the inflammation of the vulva and improved most of the clinical signs and symptoms associated with VLS. Nonetheless, no improvement in vulvar skin elasticity was derived from the autologous treatment.

Level of Evidence I

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM (1988) Lichen sclerosus et atrophicus and autoimmunity–a study of 350 women. Br J Dermatol 118(1):41–46CrossRef
2.
Cox NH, Mitchell JN, Morley WN (1986) Lichen sclerosus et atrophicus in non-identical female twins. Br J Dermatol 115:743–746CrossRef
3.
Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F (2010) The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol 24:1031–1034PubMed
4.
Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K (2000) Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 142:481–484CrossRef
5.
Oyama N, Chan I, Neill SM et al (2003) Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 362:118–123CrossRef
6.
Powell JJ, Wojnarowska F (1999) Lichen sclerosus. Lancet 353(9166):1777–1783CrossRef
7.
Goldstein AT, Marinoff SC, Christopher K, Srodon M (2005) Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 50(7):477–480PubMed
8.
Sadowsky LM, Schlosser BJ (2019) Vulvar squamous cell carcinoma in a patient with vulvar lichen sclerosus. JAMA Dermatol 155(7):844CrossRef
9.
Lewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F et al (2018) British association of dermatologists guidelines for the management of lichen sclerosus. Br J Dermatol 178(4):839–853CrossRef
10.
Singh N, Mishra N, Ghatage P (2021) Treatment options in vulvar lichen sclerosus: a scoping review. Cureus 13(2):e13527PubMedPubMedCentral
11.
Ohshima H, Kinoshita S, Oyobikawa M, Futagawa M, Takiwaki H, Ishiko A et al (2013) Use of Cutometer area parameters in evaluating age-related changes in the skin elasticity of the cheek. Skin Res Technol 19(1):e238–e242CrossRef
12.
Woo MS, Moon KJ, Jung HY, Park SR, Moon TK, Kim NS et al (2014) Comparison of skin elasticity test results from the Ballistometer(®) and Cutometer(®). Skin Res Technol 20(4):422–428CrossRef
13.
Günthert AR, Duclos K, Jahns BG, Krause E, Amann E, Limacher A et al (2012) Clinical scoring system for vulvar lichen sclerosus. J Sex Med 9(9):2342–2350CrossRef
14.
Chren M-M (2012) The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin 30(2):231–236CrossRef
15.
Jones-Caballero M, Peñas PF, García-Díez A, Chren MM, Badía X (2002) The Spanish version of Skindex-29 an instrument for measuring quality of life in patients with cutaneous diseases. Med Clin (Barc) 118(1):5–9CrossRef
16.
Krapf JM, Mitchell L, Holton MA, Goldstein AT (2020) Vulvar lichen sclerosus: current perspectives. Int J Womens Health 12:11–20CrossRef
17.
Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L (2004) Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 140(6):709–712CrossRef
18.
Mojallal A, Lequeux C, Shipkov C, Breton P, Foyatier JL, Braye F et al (2009) Improvement of skin quality after fat grafting: clinical observation and an animal study. Plast Reconstr Surg 124(3):765–774CrossRef
19.
Eshtiaghi P, Sadownik LA (2019) Fact or fiction? adipose-derived stem cells and platelet-rich plasma for the treatment of vulvar lichen sclerosus. J Low Genit Tract Dis 23(1):65–70CrossRef
20.
Ersek RA (1991) Transplantation of purified autologous fat: a 3-year follow-up is disappointing. Plast Reconstr Surg 87(2):219–227CrossRef
21.
Casabona F, Priano V, Vallerino V, Cogliandro A, Lavagnino G (2010) New surgical approach to lichen sclerosus of the vulva: the role of adipose-derived mesenchymal cells and platelet-rich plasma in tissue regeneration. Plast Reconstr Surg 126(4):210e-e211CrossRef
22.
Giuseppina Onesti M, Carella S, Ceccarelli S, Marchese C, Scuderi N (2016) The use of human adipose-derived stem cells in the treatment of physiological and pathological vulvar dystrophies. Stem Cells Int 2016:2561461CrossRef
23.
Boero V, Brambilla M, Sipio E, Liverani CA, Di Martino M, Agnoli B et al (2015) Vulvar lichen sclerosus: a new regenerative approach through fat grafting. Gynecol Oncol 139(3):471–475CrossRef
24.
La CL (2017) Perspectiva del paciente del ensayo clínico. Investig Rev Cubana Salud Pública 43(3):373–95
25.
26.
Gause TM 2nd, Kling RE, Sivak WN, Marra KG, Rubin JP, Kokai LE (2014) Particle size in fat graft retention: a review on the impact of harvesting technique in lipofilling surgical outcomes. Adipocyte 3(4):273–279CrossRef
27.
Andia I, Maffulli N (2013) Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 9(12):721–730CrossRef
28.
29.
Guillén MI, Platas J, Pérez Del Caz MD, Mirabet V, Alcaraz MJ (2018) Paracrine anti-inflammatory effects of adipose tissue-derived mesenchymal stem cells in human monocytes. Front Physiol 9:661CrossRef
30.
31.
Ceserani V, Ferri A, Berenzi A, Benetti A, Ciusani E, Pascucci L et al (2016) Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells. Vasc Cell 8(1):1–2CrossRef
32.
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13(12):4279–4295CrossRef
33.
Heo SC, Jeon ES, Lee IH, Kim HS, Kim MB, Kim JH (2011) Tumor necrosis factor-α-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Investig Dermatol 131(7):1559–1567CrossRef
34.
Bendinelli P, Matteucci E, Dogliotti G, Corsi MM, Banfi G, Maroni P et al (2010) Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol 225(3):757–766CrossRef
35.
Sundman EA, Cole BJ, Karas V, Della Valle C, Tetreault MW, Mohammed HO et al (2014) The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 42(1):35–41CrossRef
36.
Descalzi F, Ulivi V, Cancedda R, Piscitelli F, Luongo L, Guida F et al (2013) Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism. Tissue Eng Part A 19(19–20):2120–2129CrossRef
37.
Goldstein AT, Mitchell L, Govind V, Heller D (2019) A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 80(6):1788–1789CrossRef
Metadata
Title
The Effect of Lipofilling and Platelet-Rich Plasma on Patients with Moderate–Severe Vulvar Lichen Sclerosus who were Non-Responders to Topical Clobetasol Propionate: A Randomized Pilot Study
Publication date
20-01-2022
Published in
Aesthetic Plastic Surgery / Issue 5/2022
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-021-02718-1

Other articles of this Issue 5/2022

Aesthetic Plastic Surgery 5/2022 Go to the issue

Original Article

Efficacy of Topical Losartan in Management of Mammoplasty and Abdominoplasty Scars: A Randomized, Double-Blind Clinical Trial

Review

Effects of Silicone Breast Implants on Human Cell Types In Vitro: A Closer Look on Host and Implant

Editor’s Invited Discussion

Invited Discussion on “Body Contouring using a Combination of Pulsed Ultrasound and Unipolar Radiofrequency: A Prospective Pilot Study”

Letter to the Editor

Pectoral Muscle Re-Attachment with Breast Implant Removal

Editor’s Invited Discussion

Disussion: A Modified Large-cap Graft in East Asian Revision Rhinoplasty

Original Article

Neurotization Does not Prolong Operative Time in Free Flap Breast Reconstruction